Blinded Diagnostics To Participate In Global Multi-Center Clinical Trial Engagement

Saddle Brook, NJ - Blinded Diagnostics has been engaged to provide point of care diagnostics services to support a global multi-center clinical trial which will be conducted by a major pharmaceutical company starting this year. This multi-center trial will utilize two different point of care devices to perform tests at the beginning of the patient enrollment period.

Steve Karuppan, CEO of Blinded Diagnostics stated “We are pleased to be selected in this innovative effort to provide strategic efficiencies in a large scale global trial”. Mr. Karuppan also noted that “the ever expanding portfolio for same day test results holds the promise for even more opportunities in the future”.

This point of care diagnostic technology will be utilized at several hundred sites, on six continents. As a component of the overall program, Blinded Diagnostics will provide training for all sites in the proper use of the devices for the trial. The point of care devices are expected to be used for over two years in this trial.

About Blinded Diagnostics
A pioneering contract service organization specializing in sourcing and supporting point of care diagnostic test platforms that provide same day lab test results for pharmaceutical clinical trials. Blinded Diagnostics has a successful track record of expertise in meeting large pharmaceutical company testing needs with thorough knowledge of the protocol design, Investigator training and firmware encryption. As an innovator with partners in point-of-care diagnostics, Blinded Diagnostics is at the forefront of a paradigm shift that brings flexibility and efficiency for trial sponsors.